Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Can AI reveal complex patterns in biological data?

Can artificial intelligence be used to extract genomic data and discover relevant biomarkers? Immune-focused AI technology company CytoReason thinks so. Sally Turner finds out more from co-founder and president David Harel, including how scientists were able to predict who will respond to anti-TNF drugs such as Remicade.

Close
Close
Close

Go Top